 | • レポートコード：GIR-105X01982 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、アベルマブのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。アベルマブの種類別市場規模（）、用途別市場規模（メルケル細胞癌、非小細胞肺癌（NSCLC）、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・アベルマブの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Merck、Pfizer ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年： ・用途別分析2016年-2026年：メルケル細胞癌、非小細胞肺癌（NSCLC）、その他 ・アベルマブの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・アベルマブのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・アベルマブのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・アベルマブの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・アベルマブの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Avelumab market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Avelumab size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Avelumab market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Avelumab market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Market segment by Application can be divided into
Merkel-cell Carcinoma
Non-small Cell Lung Carcinoma (NSCLC)
Other
The key market players for global Avelumab market are listed below:
Merck
Pfizer
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Avelumab Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Avelumab Revenue by Type: 2019 Versus 2021 Versus 2026
1.3 Market Analysis by Application
1.3.1 Overview: Global Avelumab Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Merkel-cell Carcinoma
1.3.3 Non-small Cell Lung Carcinoma (NSCLC)
1.3.4 Other
1.4 Global Avelumab Market Size & Forecast
1.4.1 Global Avelumab Sales in Value (2016-2026))
1.4.2 Global Avelumab Sales in Volume (2016-2026)
1.4.3 Global Avelumab Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Avelumab Production Capacity Analysis
1.5.1 Global Avelumab Total Production Capacity (2016-2026)
1.5.2 Global Avelumab Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Avelumab Market Drivers
1.6.2 Avelumab Market Restraints
1.6.3 Avelumab Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Avelumab Product and Services
2.1.4 Merck Avelumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Avelumab Product and Services
2.2.4 Pfizer Avelumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Avelumab Sales by Manufacturer
3.1 Global Avelumab Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Avelumab Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Avelumab
3.4 Market Concentration Rate
3.4.1 Top 3 Avelumab Manufacturer Market Share
3.4.2 Top 6 Avelumab Manufacturer Market Share
3.5 Global Avelumab Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Avelumab Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Avelumab Market Size by Region
4.1.1 Global Avelumab Sales in Volume by Region (2016-2026)
4.1.2 Global Avelumab Revenue by Region (2016-2026)
4.2 North America Avelumab Revenue (2016-2026)
4.3 Europe Avelumab Revenue (2016-2026)
4.4 Asia-Pacific Avelumab Revenue (2016-2026)
4.5 South America Avelumab Revenue (2016-2026)
4.6 Middle East and Africa Avelumab Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Avelumab Sales in Volume by Type (2016-2026)
5.2 Global Avelumab Revenue by Type (2016-2026)
5.3 Global Avelumab Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Avelumab Sales in Volume by Application (2016-2026)
6.2 Global Avelumab Revenue by Application (2016-2026)
6.3 Global Avelumab Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Avelumab Sales by Type (2016-2026)
7.2 North America Avelumab Sales by Application (2016-2026)
7.3 North America Avelumab Market Size by Country
7.3.1 North America Avelumab Sales in Volume by Country (2016-2026)
7.3.2 North America Avelumab Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Avelumab Sales by Type (2016-2026)
8.2 Europe Avelumab Sales by Application (2016-2026)
8.3 Europe Avelumab Market Size by Country
8.3.1 Europe Avelumab Sales in Volume by Country (2016-2026)
8.3.2 Europe Avelumab Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Avelumab Sales by Type (2016-2026)
9.2 Asia-Pacific Avelumab Sales by Application (2016-2026)
9.3 Asia-Pacific Avelumab Market Size by Region
9.3.1 Asia-Pacific Avelumab Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Avelumab Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Avelumab Sales by Type (2016-2026)
10.2 South America Avelumab Sales by Application (2016-2026)
10.3 South America Avelumab Market Size by Country
10.3.1 South America Avelumab Sales in Volume by Country (2016-2026)
10.3.2 South America Avelumab Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Avelumab Sales by Type (2016-2026)
11.2 Middle East & Africa Avelumab Sales by Application (2016-2026)
11.3 Middle East & Africa Avelumab Market Size by Country
11.3.1 Middle East & Africa Avelumab Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Avelumab Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Avelumab Typical Distributors
12.3 Avelumab Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Avelumab Revenue by Type, (USD Million), 2021-2026
Table 2. Global Avelumab Revenue by Application, (USD Million), 2021-2026
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Avelumab Product and Services
Table 6. Merck Avelumab Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Avelumab Product and Services
Table 10. Pfizer Avelumab Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Global Avelumab Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 12. Global Avelumab Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 13. Market Position of Manufacturers in Avelumab, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 14. Global Avelumab Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 15. Head Office and Avelumab Production Site of Key Manufacturer
Table 16. Global Avelumab Sales by Region (2016-2021e) & (K Pcs)
Table 17. Global Avelumab Sales by Region (2021-2026) & (K Pcs)
Table 18. Global Avelumab Revenue by Region (2016-2021e) & (USD Million)
Table 19. Global Avelumab Revenue by Region (2021-2026) & (USD Million)
Table 20. Global Avelumab Sales by Type (2016-2021e) & (K Pcs)
Table 21. Global Avelumab Sales by Type (2021-2026) & (K Pcs)
Table 22. Global Avelumab Revenue by Type (2016-2021e) & (USD Million)
Table 23. Global Avelumab Revenue by Type (2021-2026) & (USD Million)
Table 24. Global Avelumab Price by Type (2016-2021e) & (USD/Pcs)
Table 25. Global Avelumab Price by Type (2021-2026) & (USD/Pcs)
Table 26. Global Avelumab Sales by Application (2016-2021e) & (K Pcs)
Table 27. Global Avelumab Sales by Application (2021-2026) & (K Pcs)
Table 28. Global Avelumab Revenue by Application (2016-2021e) & (USD Million)
Table 29. Global Avelumab Revenue by Application (2021-2026) & (USD Million)
Table 30. Global Avelumab Price by Application (2016-2021e) & (USD/Pcs)
Table 31. Global Avelumab Price by Application (2021-2026) & (USD/Pcs)
Table 32. North America Avelumab Sales by Country (2016-2021e) & (K Pcs)
Table 33. North America Avelumab Sales by Country (2021-2026) & (K Pcs)
Table 34. North America Avelumab Revenue by Country (2016-2021e) & (USD Million)
Table 35. North America Avelumab Revenue by Country (2021-2026) & (USD Million)
Table 36. North America Avelumab Sales by Type (2016-2021e) & (K Pcs)
Table 37. North America Avelumab Sales by Type (2021-2026) & (K Pcs)
Table 38. North America Avelumab Sales by Application (2016-2021e) & (K Pcs)
Table 39. North America Avelumab Sales by Application (2021-2026) & (K Pcs)
Table 40. Europe Avelumab Sales by Country (2016-2021e) & (K Pcs)
Table 41. Europe Avelumab Sales by Country (2021-2026) & (K Pcs)
Table 42. Europe Avelumab Revenue by Country (2016-2021e) & (USD Million)
Table 43. Europe Avelumab Revenue by Country (2021-2026) & (USD Million)
Table 44. Europe Avelumab Sales by Type (2016-2021e) & (K Pcs)
Table 45. Europe Avelumab Sales by Type (2021-2026) & (K Pcs)
Table 46. Europe Avelumab Sales by Application (2016-2021e) & (K Pcs)
Table 47. Europe Avelumab Sales by Application (2021-2026) & (K Pcs)
Table 48. Asia-Pacific Avelumab Sales by Region (2016-2021e) & (K Pcs)
Table 49. Asia-Pacific Avelumab Sales by Region (2021-2026) & (K Pcs)
Table 50. Asia-Pacific Avelumab Revenue by Region (2016-2021e) & (USD Million)
Table 51. Asia-Pacific Avelumab Revenue by Region (2021-2026) & (USD Million)
Table 52. Asia-Pacific Avelumab Sales by Type (2016-2021e) & (K Pcs)
Table 53. Asia-Pacific Avelumab Sales by Type (2021-2026) & (K Pcs)
Table 54. Asia-Pacific Avelumab Sales by Application (2016-2021e) & (K Pcs)
Table 55. Asia-Pacific Avelumab Sales by Application (2021-2026) & (K Pcs)
Table 56. South America Avelumab Sales by Country (2016-2021e) & (K Pcs)
Table 57. South America Avelumab Sales by Country (2021-2026) & (K Pcs)
Table 58. South America Avelumab Revenue by Country (2016-2021e) & (USD Million)
Table 59. South America Avelumab Revenue by Country (2021-2026) & (USD Million)
Table 60. South America Avelumab Sales by Type (2016-2021e) & (K Pcs)
Table 61. South America Avelumab Sales by Type (2021-2026) & (K Pcs)
Table 62. South America Avelumab Sales by Application (2016-2021e) & (K Pcs)
Table 63. South America Avelumab Sales by Application (2021-2026) & (K Pcs)
Table 64. Middle East & Africa Avelumab Sales by Country (2016-2021e) & (K Pcs)
Table 65. Middle East & Africa Avelumab Sales by Country (2021-2026) & (K Pcs)
Table 66. Middle East & Africa Avelumab Revenue by Country (2016-2021e) & (USD Million)
Table 67. Middle East & Africa Avelumab Revenue by Country (2021-2026) & (USD Million)
Table 68. Middle East & Africa Avelumab Sales by Type (2016-2021e) & (K Pcs)
Table 69. Middle East & Africa Avelumab Sales by Type (2021-2026) & (K Pcs)
Table 70. Middle East & Africa Avelumab Sales by Application (2016-2021e) & (K Pcs)
Table 71. Middle East & Africa Avelumab Sales by Application (2021-2026) & (K Pcs)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Avelumab Typical Distributors
Table 75. Avelumab Typical Customers
List of Figures
Figure 1. Avelumab Picture
Figure 2. Global Avelumab Sales Market Share by Type in 2020
Figure 3. Global Avelumab Sales Market Share by Application in 2020
Figure 4. Merkel-cell Carcinoma
Figure 5. Non-small Cell Lung Carcinoma (NSCLC)
Figure 6. Other
Figure 7. Global Avelumab Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 8. Global Avelumab Market Size and Forecast (2016-2026) & (USD Million)
Figure 9. United States Avelumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 10. Canada Avelumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Mexico Avelumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Germany Avelumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. France Avelumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. United Kingdom Avelumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Russia Avelumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Italy Avelumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. China Avelumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Japan Avelumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Korea Avelumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. India Avelumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Southeast Asia Avelumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Australia Avelumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Brazil Avelumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Egypt Avelumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Saudi Arabia Avelumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. South Africa Avelumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Turkey Avelumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Global Avelumab Sales (2016-2026) & (K Pcs)
Figure 29. Global Avelumab Production Capacity (2016-2026) & (K Pcs)
Figure 30. Global Avelumab Production Capacity by Geographic Region: 2020 VS 2021
Figure 31. Avelumab Market Drivers
Figure 32. Avelumab Market Restraints
Figure 33. Avelumab Market Trends
Figure 34. Global Avelumab Sales Market Share by Manufacturer in 2020
Figure 35. Global Avelumab Revenue Market Share by Manufacturer in 2020
Figure 36. Avelumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 37. Top 3 Avelumab Manufacturer (Revenue) Market Share in 2020
Figure 38. Top 6 Avelumab Manufacturer (Revenue) Market Share in 2020
Figure 39. Global Avelumab Sales Market Share by Region (2016-2026)
Figure 40. Global Avelumab Revenue Market Share by Region (2016-2026)
Figure 41. North America Avelumab Revenue (2016-2026) & (USD Million)
Figure 42. Europe Avelumab Revenue (2016-2026) & (USD Million)
Figure 43. Asia-Pacific Avelumab Revenue (2016-2026) & (USD Million)
Figure 44. South America Avelumab Revenue (2016-2026) & (USD Million)
Figure 45. Middle East & Africa Avelumab Revenue (2016-2026) & (USD Million)
Figure 46. Global Avelumab Sales Market Share by Type (2016-2026)
Figure 47. Global Avelumab Revenue Market Share by Type (2016-2026)
Figure 48. Global Avelumab Price by Type (2016-2026) & (USD/Pcs)
Figure 49. Global Avelumab Sales Market Share by Application (2016-2026)
Figure 50. Global Avelumab Revenue Market Share by Application (2016-2026)
Figure 51. Global Avelumab Price by Application (2016-2026) & (USD/Pcs)
Figure 52. North America Avelumab Sales Market Share by Country (2016-2026)
Figure 53. North America Avelumab Revenue Market Share by Country (2016-2026)
Figure 54. North America Avelumab Sales Market Share by Type (2016-2026)
Figure 55. North America Avelumab Sales Market Share by Application (2016-2026)
Figure 56. Europe Avelumab Sales Market Share by Country (2016-2026)
Figure 57. Europe Avelumab Revenue Market Share by Country (2016-2026)
Figure 58. Europe Avelumab Sales Market Share by Type (2016-2026)
Figure 59. Europe Avelumab Sales Market Share by Application (2016-2026)
Figure 60. Asia-Pacific Avelumab Sales Market Share by Region (2016-2026)
Figure 61. Asia-Pacific Avelumab Revenue Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Avelumab Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Avelumab Sales Market Share by Application (2016-2026)
Figure 64. South America Avelumab Sales Market Share by Country (2016-2026)
Figure 65. South America Avelumab Revenue Market Share by Country (2016-2026)
Figure 66. South America Avelumab Sales Market Share by Type (2016-2026)
Figure 67. South America Avelumab Sales Market Share by Application (2016-2026)
Figure 68. Middle East & Africa Avelumab Sales Market Share by Country (2016-2026)
Figure 69. Middle East & Africa Avelumab Revenue Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Avelumab Sales Market Share by Type (2016-2026)
Figure 71. Middle East & Africa Avelumab Sales Market Share by Application (2016-2026)
Figure 72. Sales Channel: Direct Channel vs Indirect Channel
Figure 73. Methodology
Figure 74. Research Process and Data Source
小細胞肺がん治療薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Lung cancer can be categorized into two types: non-small cell lung cancer and small cell lung cancer. Small cell lung cancer constitutes roughly 10-15 percent of all diagnosed cases of lung cancer. Small cell lung cancer is categorized into two types: small cell carcinoma and combined small cell car…- 肝細胞がん治療薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 HCC is the most common form of primary liver cancer in adults and occurs mainly in the patients with underlying liver disease and cirrhosis. The disease originates in the liver unlike the secondary liver cancers which reaches to the liver from other organs of the body. Currently only two drugs NEXAV…
- スモールセルネットワークの世界市場予測 2023年：メーカー別、地域別、種類・用途別 Small cells are low-powered cellular radio access nodes that operate in licensed and unlicensed spectrum that have a range of 10 meters to a few kilometers. They are "small" compared to a mobile macrocell, partly because they have a shorter range and partly because they typically handle fewer concur…
- 尿路上皮癌診断の世界市場2018-2025 Urothelial Carcinoma or Transitional Cell Carcinoma encompasses cancer in different parts of urinary tract like kidney, bladder, ureters, and renal pelvis.The increasing trends of cigarette smoking is increasing the chances of urothelial carcinoma manifold. The Urothelial Carcinoma Diagnostics marke…
- 世界のロルラチニブ市場 2021：企業別、地域別、種類・用途別 The Lorlatinib market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent …